673 related articles for article (PubMed ID: 8640617)
1. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
2. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study.
Ramchandani M; Reddy DN; Gupta R; Lakhtakia S; Tandan M; Darisetty S; Sekaran A; Rao GV
Gastrointest Endosc; 2011 Sep; 74(3):511-9. PubMed ID: 21737076
[TBL] [Abstract][Full Text] [Related]
3. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
4. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
5. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
6. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses.
Lee WJ; Lim HK; Jang KM; Kim SH; Lee SJ; Lim JH; Choo IW
Radiographics; 2001 Oct; 21 Spec No():S97-S116. PubMed ID: 11598251
[TBL] [Abstract][Full Text] [Related]
7. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ
J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.
Erdogan D; Kloek JJ; ten Kate FJ; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
Br J Surg; 2008 Jun; 95(6):727-34. PubMed ID: 18418862
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP.
Yu XR; Huang WY; Zhang BY; Li HQ; Geng DY
Clin Radiol; 2014 Jun; 69(6):567-73. PubMed ID: 24581958
[TBL] [Abstract][Full Text] [Related]
11. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
13. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
Corvera CU; Blumgart LH; Darvishian F; Klimstra DS; DeMatteo R; Fong Y; D'Angelica M; Jarnagin WR
J Am Coll Surg; 2005 Dec; 201(6):862-9. PubMed ID: 16310689
[TBL] [Abstract][Full Text] [Related]
15. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
16. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of benign biliary strictures masquerading as biliary malignancy.
Wakai T; Shirai Y; Sakata J; Maruyama T; Ohashi T; Korira PV; Ajioka Y; Hatakeyama K
Am Surg; 2012 Dec; 78(12):1388-91. PubMed ID: 23265129
[TBL] [Abstract][Full Text] [Related]
18. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.
Nguyen Canh H; Harada K
Med Mol Morphol; 2016 Dec; 49(4):189-202. PubMed ID: 27350291
[TBL] [Abstract][Full Text] [Related]
19. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
20. Predictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology.
Navaneethan U; Singh T; Gutierrez NG; Jegadeesan R; Venkatesh PG; Brainard J; Vargo JJ; Parsi MA
J Dig Dis; 2014 May; 15(5):268-75. PubMed ID: 24612456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
